This technical overview details the molecular mechanisms, receptor binding characteristics, and laboratory handling procedures for the ipamorelin research peptide and its co-administration with GHRH analogs in preclinical settings.
This technical overview details the molecular mechanisms, receptor binding characteristics, and laboratory handling procedures for the ipamorelin research peptide and its co-administration with GHRH analogs in preclinical settings.
An ipamorelin research peptide is a synthetic pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) classified as a highly selective growth hormone secretagogue and ghrelin receptor (GHS-R1a) agonist. In preclinical investigation, it is studied for its ability to stimulate growth hormone release without elevating plasma cortisol, prolactin, or aldosterone levels.
Unlike non-selective secretagogues, the ipamorelin research peptide demonstrates a high degree of receptor specificity in vitro. Researchers frequently evaluate this compound to explore somatic cell growth, cellular repair mechanisms, and metabolic signaling pathways without the confounding endocrinological noise caused by non-target hormone elevation.
In laboratory models evaluating pituitary GH secretion, combining a Growth Hormone Releasing Hormone (GHRH) analog with a Growth Hormone Releasing Peptide (GHRP) yields a potent synergistic effect. Examining the cjc-1295 ipamorelin research peptide dual-agent model allows investigators to analyze dual-pathway activation at the somatotrope receptor level.
CJC-1295 acts directly upon the GHRH receptor, triggering adenylate cyclase activation and intracellular cAMP accumulation. Simultaneously, Ipamorelin binds the GHS-R1a receptor to trigger phospholipase C and intracellular calcium influx. Preclinical studies suggest that co-incubating somatotropes with both pathways simultaneously results in a amplified, pulsatile release of GH that exceeds the additive sums of either isolated peptide.
To review full analytical data across multiple secretagogue classes, explore the comprehensive PX1 research library for comparative in vitro methodologies.
Understanding the biochemical distinctions between these two secretagogues is critical for designing controlled bench assays. CJC-1295 is a modified 29-amino acid GHRH analog. As a long-acting growth-hormone-releasing hormone analog, CJC-1295 DAC incorporates a Drug Affinity Complex (DAC) reactive group that bioconjugates to serum albumin, extending its biological half-life in animal models to several days and sustaining downstream IGF-1 levels for tissue repair research.
Conversely, CJC-1295 No DAC (also referred to as Modified GRF 1-29) lacks this bioconjugating moiety, presenting a significantly shorter half-life (approximately 30 minutes in rodent models) ideal for mimicking acute, physiological GH pulses.
Ipamorelin, on the other hand, does not target the GHRH receptor. It operates exclusively via ghrelin receptor activation. Because its mechanism of action is completely distinct from GHRH peptides, combining them allows researchers to study complete secretagogue cascade dynamics.
A standard protocol for preparing lyophilized peptides involves precise reconstitution under sterile laminar flow conditions. Researchers frequently inquire regarding how to mix cjc 1295 with dac and bacteriostatic water to ensure compound integrity, prevent shear stress aggregation, and maintain sterility over multiple analytical runs.
To reconstitute, clear the rubber stopper of the lyophilized vial with a laboratory grade alcohol wipe. Using a sterile syringe, draw the exact volume of bacteriostatic water required for your intended research concentration. Slowly introduce the diluent down the glass inside wall of the vial. Never spray liquid directly onto the lyophilized peptide cake, as high kinetic force can disrupt fragile tertiary structures.
Gently swirl the vial in a smooth circular motion until the lyophilized powder is completely dissolved. Avoid violent agitation, shaking, or vortexing. For specific concentration math and diluent volumetric calculations, scientists can utilize our online peptide reconstitution calculator.
Research validity depends entirely upon compound purity and structural integrity. PX1 Research adheres to rigorous USA manufacturing standards, producing research peptides in GMP-compliant facilities subject to independent ISO 17025 laboratory verification.
Every production lot undergoes rigorous dual-stage testing: Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity (exceeding 99%), and Mass Spectrometry (MS) to confirm exact molecular mass. Furthermore, all lots undergo chromogenic LAL assays for endotoxin testing, ensuring endotoxin levels remain strictly below standard experimental thresholds (<0.01 EU/mg).
Every shipment includes a verifiable, lot-specific Certificate of Analysis (COA). Researchers can review verified specifications directly across our full catalog of all peptides.
Lyophilized peptide vials should be stored at -20°C prior to reconstitution for long-term stability. Exposure to repeated freeze-thaw cycles must be strictly avoided to prevent physical degradation of the peptide chain.
Once reconstituted with bacteriostatic water 30ml containing 0.9% benzyl alcohol, liquid aliquots remain stable under refrigeration at 2°C to 8°C for up to 28–30 days. The benzyl alcohol acts as a bacteriostatic agent, inhibiting microbial growth during repeated sample draws. For prolonged experimental timelines beyond 30 days, sub-aliquoting the solution into sterile microcentrifuge tubes and freezing at -80°C is recommended.
Preclinical rodent models evaluating GHRH analogs demonstrate sustained elevation of systemic growth hormone (GH) and downstream Insulin-like Growth Factor 1 (IGF-1). In vivo data indicate that chronic activation of the GH/IGF-1 axis plays a central role in extracellular matrix synthesis, cellular proliferation, and microvascular tissue repair research.
When evaluated in vitro using osteoblast and myoblast cultures, exposure to ipamorelin and GHRH combinations demonstrates enhanced collagen mRNA expression and elevated protein synthesis rates. Researchers utilize these findings to model muscle wasting recovery, skeletal tissue density maintenance, and wound healing kinetics.
Selecting the correct secretagogue for an experimental protocol requires evaluating receptor affinity and collateral hormone release. When comparing the ipamorelin research peptide to older ghrelin receptor agonists, clear differences emerge in receptor selectivity and neuroendocrine side profiles.
For instance, in our detailed technical review on ghrp-6 vs ipamorelin, GHRP-6 demonstrates robust GH release but significantly stimulates cortisol and ACTH secretion while markedly increasing appetite signaling via NPY activation in animal models. Ipamorelin exhibits zero affinity for NPY receptors and does not elevate cortisol or prolactin.
Similarly, comparing GHRH analogs in our analysis of sermorelin vs ipamorelin highlights that Sermorelin consists of the native 1-29 amino acid sequence with a short half-life, whereas CJC-1295 features substituted amino acids (D-Ala, Gln, Ala, Leu at positions 2, 8, 15, 27) that resist enzymatic degradation by dipeptidyl peptidase IV (DPP-IV).
PX1 Research provides dependable supply chains for university labs, contract research organizations (CROs), and private scientific facilities across the United States. All orders ship directly from domestic centers in California and Arizona, with same-day shipping available Monday through Friday.
For large-scale, ongoing preclinical projects, laboratories can register for a wholesale account via our wholesale portal to access bulk pricing, customized vial configurations, and dedicated analytical lot reservation.
What is an ipamorelin research peptide?
An ipamorelin research peptide is a synthetic pentapeptide growth hormone secretagogue that selectively targets the ghrelin/GHS-R1a receptor in laboratory models to induce growth hormone release without raising cortisol or prolactin.
How to mix cjc 1295 with dac and bacteriostatic water?
To mix CJC-1295 with DAC and bacteriostatic water for lab use, sanitize the vial stopper, draw the required volume of bacteriostatic water with a sterile syringe, and slowly inject it against the glass vial wall. Gently swirl the container until the lyophilized powder completely dissolves without shaking.
What defines the cjc-1295 ipamorelin research peptide combination in preclinical models?
The cjc-1295 ipamorelin research peptide combination represents a dual-mechanism GHRH analog and GHRP pairing. In vitro somatotrope studies show that activating both cAMP and IP3 pathways concurrently yields synergistic growth hormone secretion.
Why is bacteriostatic water preferred over sterile water for peptide reconstitution?
Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth, allowing multiple withdrawals over a 28-day period. Sterile water lacks preservatives and must be used immediately upon opening.
What is the difference between CJC-1295 with DAC and CJC-1295 without DAC?
CJC-1295 with DAC contains a Drug Affinity Complex that covalently binds to blood albumin, extending its biological half-life to several days. CJC-1295 without DAC (Mod GRF 1-29) lacks this complex, resulting in a half-life of roughly 30 minutes for acute pulse studies.
How should reconstituted research peptides be stored to prevent degradation?
Reconstituted peptides must be kept refrigerated at 2°C to 8°C and protected from light. Under these conditions with bacteriostatic water, compounds maintain chemical stability for up to 30 days.
What endotoxin limits does PX1 Research guarantee?
PX1 Research verifies that all peptide lots test below <0.01 EU/mg via chromogenic LAL assay, making them suitable for sensitive cell culture and preclinical laboratory applications.
How does Ipamorelin differ from older GHRPs like GHRP-2 or GHRP-6?
Ipamorelin is significantly more selective than GHRP-2 or GHRP-6. Preclinical data confirm that Ipamorelin does not stimulate cortisol, prolactin, or appetite center pathways (NPY).
Can research institutions order high-purity peptides in wholesale quantities?
Yes. Qualified academic and private research institutions can access bulk sizing, custom synthesis, and dedicated lot reservations through the PX1 Research wholesale program.
What analytical documentation is included with PX1 Research compounds?
Every lot is accompanied by a Certificate of Analysis (COA) detailing RP-HPLC purity determination, mass spectrometry identity confirmation, and endotoxin assay results.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.